Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Arcutis Biotherapeutics Inc (NASDAQ: ARQT) was $12.39 for the day, down -4.84% from the previous closing price of $13.02. In other words, the price has decreased by -$4.84 from its previous closing price. On the day, 1.54 million shares were traded.
Ratios:
Our analysis of ARQT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.38 and its Current Ratio is at 2.46. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 0.69.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $19.
On August 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.
Mizuho Upgraded its Neutral to Buy on January 03, 2024, whereas the target price for the stock was revised from $4 to $8.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 03 ’25 when Matsuda Masaru sold 8,338 shares for $12.70 per share. The transaction valued at 105,893 led to the insider holds 178,692 shares of the business.
Watanabe Todd Franklin sold 19,301 shares of ARQT for $245,123 on Feb 03 ’25. The insider now owns 804,129 shares after completing the transaction at $12.70 per share. On Feb 03 ’25, another insider, Welgus Howard G., who serves as the Director of the company, sold 10,000 shares for $12.71 each. As a result, the insider received 127,100 and left with 141,944 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 10.45 while its Price-to-Book (P/B) ratio in mrq is 9.25.
Stock Price History:
Over the past 52 weeks, ARQT has reached a high of $16.20, while it has fallen to a 52-week low of $6.99. The 50-Day Moving Average of the stock is -8.46%, while the 200-Day Moving Average is calculated to be 17.05%.
Shares Statistics:
A total of 117.00M shares are outstanding, with a floating share count of 103.03M. Insiders hold about 11.97% of the company’s shares, while institutions hold 103.15% stake in the company.
